1. Home
  2. TKC vs GRFS Comparison

TKC vs GRFS Comparison

Compare TKC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKC
  • GRFS
  • Stock Information
  • Founded
  • TKC 1993
  • GRFS 1940
  • Country
  • TKC Turkey
  • GRFS Spain
  • Employees
  • TKC N/A
  • GRFS N/A
  • Industry
  • TKC Telecommunications Equipment
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TKC Telecommunications
  • GRFS Health Care
  • Exchange
  • TKC Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • TKC 5.2B
  • GRFS 5.9B
  • IPO Year
  • TKC 2000
  • GRFS 2006
  • Fundamental
  • Price
  • TKC $5.64
  • GRFS $8.80
  • Analyst Decision
  • TKC
  • GRFS Hold
  • Analyst Count
  • TKC 0
  • GRFS 1
  • Target Price
  • TKC N/A
  • GRFS $10.30
  • AVG Volume (30 Days)
  • TKC 1.4M
  • GRFS 771.2K
  • Earning Date
  • TKC 11-06-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • TKC 4.19%
  • GRFS 1.62%
  • EPS Growth
  • TKC N/A
  • GRFS N/A
  • EPS
  • TKC 0.11
  • GRFS 0.64
  • Revenue
  • TKC $4,451,876,110.00
  • GRFS $8,821,017,248.00
  • Revenue This Year
  • TKC $41.96
  • GRFS $5.31
  • Revenue Next Year
  • TKC $29.67
  • GRFS $6.02
  • P/E Ratio
  • TKC $21.02
  • GRFS $16.95
  • Revenue Growth
  • TKC N/A
  • GRFS 7.31
  • 52 Week Low
  • TKC $5.35
  • GRFS $6.19
  • 52 Week High
  • TKC $7.63
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • TKC 42.89
  • GRFS 47.98
  • Support Level
  • TKC $5.58
  • GRFS $8.33
  • Resistance Level
  • TKC $5.79
  • GRFS $8.64
  • Average True Range (ATR)
  • TKC 0.08
  • GRFS 0.22
  • MACD
  • TKC -0.01
  • GRFS 0.04
  • Stochastic Oscillator
  • TKC 41.18
  • GRFS 80.14

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: